In a nutshell Nearly half (48%) of depression patients don’t respond to standard treatments, revealing a significant gap in ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Depression and anxiety affect approximately 40% of adults with chronic pain, according to a massive new systematic review and ...

An international team led by UPV/EHU and Biobizkaia reveals the relationship between placental DNA methylation and certain ...

From medications to neuromodulation, lifestyle changes, and emerging therapies, understand the latest evidence and best ...

A study published March 17 in JAMA Network Open found that transgender, nonbinary and gender-diverse people who were ...

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.

A new study highlights the placenta’s role in neuropsychiatric development, showing that DNA methylation influences gene ...

An international team has identified associations between modifications in the placenta and the risk of developing schizophrenia, bipolar disorder, and major depression disorder.

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good thing? And is depression weight loss even a thing in the first place?

The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...